UPJOHN BROPIRIMINE SHOWS 51% COMPLETE RESPONSE RATE FOR BLADDER CARCINOMA
Executive Summary
UPJOHN BROPIRIMINE SHOWS 51% COMPLETE RESPONSE RATE FOR BLADDER CARCINOMA in a Phase II trial presented by Michael Sarosdy, MD, University of Texas, San Antonio, to the American Society of Clinical Oncology in Dallas May 17. A 3 g dally dose of the oral interferon inducer resulted in complete responses in 20 of 39 evaluable patients with bladder carcinoma in situ.